Background Cardiovascular autonomic dysfunction may reportedly occur after a coronavirus‐
disease‐2019 (COVID‐19) infection, but the available evidence is scattered. Here we …

Post-acute sequelae of SARS-CoV-2 (PASC), or long COVID syndrome, is emerging as a
major health issue in patients with previous SARS-CoV-2 infection. Symptoms commonly …

Introduction On March 11, 2020, the World Health Organization sounded the COVID-19
pandemic alarm. While efforts in the first few months focused on reducing the mortality of …

Purpose Post-COVID-19 syndrome is a poorly understood aspect of the current pandemic,
with clinical features that overlap with symptoms of autonomic/small fiber dysfunction. An …

Background Many COVID-19 patients are left with symptoms several months after resolution
of the acute illness; this syndrome is known as post-acute sequalae of COVID-19 (PASC) …

The autonomic nervous system (ANS) can be affected by COVID-19, and dysautonomia may
be a possible complication in post-COVID individuals. Orthostatic hypotension (OH) and …

Background The association between autonomic dysfunction and long‐COVID syndrome is
established. However, the prevalence and patterns of symptoms of dysautonomia in long …

Emerging evidence suggests that COVID-19 may affect cardiac autonomic function;
however, the limited findings in young adults with COVID-19 have been equivocal. Notably …

Background Autonomic dysfunction is a known complication of post-acute sequelae of
SARS-CoV-2 (PASC)/long COVID, however prevalence and severity are unknown …

Background Recent studies reported a long-lasting effect of COVID-19 infection that extends
beyond the active disease and disrupts various body systems besides the respiratory …